About tong ren tang techn. - TGRNF
Tong Ren Tang Technologies Co., Ltd. engages in the production and distribution of Chinese medicine. It operates through The Company and Tong Ren Tang Chinese Medicine segments. The Company segment manufactures and sells Chinese medicine. The Tong Ren Tang Chinese Medicine segment involves in manufacturing, retailing, and wholesale of Chinese medicine products and healthcare products. The company was founded on March 22, 2000 and is headquartered in Beijing, China.
TGRNF At a Glance
Tong Ren Tang Technologies Co., Ltd.
No.20 Nansanhuan Zhonglu
Beijing, Beijing 100079
| Phone | 86-10-6705-6924 | Revenue | 956.02M | |
| Industry | Pharmaceuticals: Major | Net Income | 83.30M | |
| Sector | Health Technology | 2023 Sales Growth | 7.439% | |
| Fiscal Year-end | 12 / 2024 | Employees | 4,101 | |
| View SEC Filings |
TGRNF Valuation
| P/E Current | 9.144 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 12.905 |
| Price to Sales Ratio | 1.124 |
| Price to Book Ratio | 1.106 |
| Price to Cash Flow Ratio | 11.872 |
| Enterprise Value to EBITDA | 5.615 |
| Enterprise Value to Sales | 1.154 |
| Total Debt to Enterprise Value | 0.208 |
TGRNF Efficiency
| Revenue/Employee | 233,119.92 |
| Income Per Employee | 20,312.295 |
| Receivables Turnover | 6.807 |
| Total Asset Turnover | 0.517 |
TGRNF Liquidity
| Current Ratio | 4.493 |
| Quick Ratio | 2.356 |
| Cash Ratio | 1.869 |
TGRNF Profitability
| Gross Margin | 41.596 |
| Operating Margin | 16.477 |
| Pretax Margin | 17.159 |
| Net Margin | 8.713 |
| Return on Assets | 4.502 |
| Return on Equity | 8.75 |
| Return on Total Capital | 6.937 |
| Return on Invested Capital | 7.248 |
TGRNF Capital Structure
| Total Debt to Total Equity | 23.619 |
| Total Debt to Total Capital | 19.106 |
| Total Debt to Total Assets | 12.047 |
| Long-Term Debt to Equity | 21.423 |
| Long-Term Debt to Total Capital | 17.33 |